MintNeuro and Motif Neurotech Partner to Advance Miniature Brain-Computer Interface Therapy for Mental Health

MintNeuro and Motif Neurotech have announced a strategic partnership aimed at developing a miniature brain-computer interface (BCI) therapy for mental health conditions. The collaboration will combine MintNeuro’s advanced neural sensing and stimulation chips with Motif’s implantable device platform, facilitating the clinical application of therapeutic BCIs. Motif is working on a fully implantable device to treat conditions like treatment-resistant depression and has received FDA approval for trials. The partnership underscores the companies’ commitment to innovating mental health therapies through advanced technology.